首页> 外文期刊>Advances in Interventional Cardiology: Postepy w Kardiologii Interwencyjnej >Case report Immunosuppressive therapy induced coronary vasospasm and acute myocardial infarction in a patient undergoing new renal transplantation
【24h】

Case report Immunosuppressive therapy induced coronary vasospasm and acute myocardial infarction in a patient undergoing new renal transplantation

机译:病例报告免疫抑制疗法在接受新肾移植的患者中诱发冠状血管痉挛和急性心肌梗死

获取原文
获取外文期刊封面目录资料

摘要

Immunosuppressant agents such as calcineurin inhibitors (CNI) used after solid organ transplantation may cause endothelial dysfunction, and coronary and renal arterial vasospasm. We report a patient presenting acute ST segment elevation myocardial infarction (STEMI) at the second week of renal transplantation. In the case of STEMI in patients with solid organ transplants under immunosuppressive therapy with CNI, coronary vasospasm associated with these drugs should be kept in mind before starting any interventional procedure. High dose nitroglycerine may immediately resolve tacrolimus or cyclosporine A induced coronary vasospasm. Calcium channel blockers should immediately be added to treatment because of the short half-life of nitroglycerine.
机译:实体器官移植后使用的免疫抑制剂,例如钙调神经磷酸酶抑制剂(CNI),可能会导致内皮功能障碍以及冠状动脉和肾动脉血管痉挛。我们报告一名患者在肾移植的第二周出现急性ST段抬高型心肌梗塞(STEMI)。对于使用CNI进行免疫抑制治疗的实体器官移植患者的STEMI,在开始任何介入治疗之前,应牢记与这些药物相关的冠状血管痉挛。高剂量的硝酸甘油可立即解决他克莫司或环孢素A引起的冠状动脉痉挛。由于硝化甘油的半衰期短,应立即将钙通道阻滞剂加入治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号